IBDEI330 ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,49206,0)
;;=C24.9^^187^2437^7
;;^UTILITY(U,$J,358.3,49206,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49206,1,3,0)
;;=3^Malig Neop Biliary Tract,Unspec
;;^UTILITY(U,$J,358.3,49206,1,4,0)
;;=4^C24.9
;;^UTILITY(U,$J,358.3,49206,2)
;;=^5000942
;;^UTILITY(U,$J,358.3,49207,0)
;;=C90.00^^187^2437^25
;;^UTILITY(U,$J,358.3,49207,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49207,1,3,0)
;;=3^Multiple Myeloma,Not in Remission
;;^UTILITY(U,$J,358.3,49207,1,4,0)
;;=4^C90.00
;;^UTILITY(U,$J,358.3,49207,2)
;;=^5001752
;;^UTILITY(U,$J,358.3,49208,0)
;;=C85.89^^187^2437^29
;;^UTILITY(U,$J,358.3,49208,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49208,1,3,0)
;;=3^NHL NEC,Extranodal & Solid Organ
;;^UTILITY(U,$J,358.3,49208,1,4,0)
;;=4^C85.89
;;^UTILITY(U,$J,358.3,49208,2)
;;=^5001730
;;^UTILITY(U,$J,358.3,49209,0)
;;=C79.51^^187^2437^33
;;^UTILITY(U,$J,358.3,49209,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49209,1,3,0)
;;=3^Secondary Malig Neop Bone
;;^UTILITY(U,$J,358.3,49209,1,4,0)
;;=4^C79.51
;;^UTILITY(U,$J,358.3,49209,2)
;;=^5001350
;;^UTILITY(U,$J,358.3,49210,0)
;;=C79.52^^187^2437^32
;;^UTILITY(U,$J,358.3,49210,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49210,1,3,0)
;;=3^Secondary Malig Neop Bone Marrow
;;^UTILITY(U,$J,358.3,49210,1,4,0)
;;=4^C79.52
;;^UTILITY(U,$J,358.3,49210,2)
;;=^5001351
;;^UTILITY(U,$J,358.3,49211,0)
;;=C92.00^^187^2437^26
;;^UTILITY(U,$J,358.3,49211,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49211,1,3,0)
;;=3^Myelobl Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49211,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,49211,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,49212,0)
;;=C92.40^^187^2437^31
;;^UTILITY(U,$J,358.3,49212,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49212,1,3,0)
;;=3^Promyelocyt Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49212,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,49212,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,49213,0)
;;=C92.50^^187^2437^28
;;^UTILITY(U,$J,358.3,49213,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49213,1,3,0)
;;=3^Myelomonocyt Leuk,Acute,No Remiss
;;^UTILITY(U,$J,358.3,49213,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,49213,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,49214,0)
;;=C78.7^^187^2437^37
;;^UTILITY(U,$J,358.3,49214,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49214,1,3,0)
;;=3^Secondary Malig Neop Liver & Intrahep BD
;;^UTILITY(U,$J,358.3,49214,1,4,0)
;;=4^C78.7
;;^UTILITY(U,$J,358.3,49214,2)
;;=^5001339
;;^UTILITY(U,$J,358.3,49215,0)
;;=C91.10^^187^2437^5
;;^UTILITY(U,$J,358.3,49215,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49215,1,3,0)
;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
;;^UTILITY(U,$J,358.3,49215,1,4,0)
;;=4^C91.10
;;^UTILITY(U,$J,358.3,49215,2)
;;=^5001765
;;^UTILITY(U,$J,358.3,49216,0)
;;=D46.9^^187^2437^27
;;^UTILITY(U,$J,358.3,49216,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49216,1,3,0)
;;=3^Myelodysplastic Syndrome,Unspec
;;^UTILITY(U,$J,358.3,49216,1,4,0)
;;=4^D46.9
;;^UTILITY(U,$J,358.3,49216,2)
;;=^334031
;;^UTILITY(U,$J,358.3,49217,0)
;;=C79.31^^187^2437^34
;;^UTILITY(U,$J,358.3,49217,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,49217,1,3,0)
;;=3^Secondary Malig Neop Brain
;;^UTILITY(U,$J,358.3,49217,1,4,0)
;;=4^C79.31
;;^UTILITY(U,$J,358.3,49217,2)
;;=^5001347
;;^UTILITY(U,$J,358.3,49218,0)
;;=C79.32^^187^2437^35
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI330 3744 printed Apr 09, 2024@21:35:33 Page 2
IBDEI330 ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,49206,0)
+2 ;;=C24.9^^187^2437^7
+3 ;;^UTILITY(U,$J,358.3,49206,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,49206,1,3,0)
+6 ;;=3^Malig Neop Biliary Tract,Unspec
+7 ;;^UTILITY(U,$J,358.3,49206,1,4,0)
+8 ;;=4^C24.9
+9 ;;^UTILITY(U,$J,358.3,49206,2)
+10 ;;=^5000942
+11 ;;^UTILITY(U,$J,358.3,49207,0)
+12 ;;=C90.00^^187^2437^25
+13 ;;^UTILITY(U,$J,358.3,49207,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,49207,1,3,0)
+16 ;;=3^Multiple Myeloma,Not in Remission
+17 ;;^UTILITY(U,$J,358.3,49207,1,4,0)
+18 ;;=4^C90.00
+19 ;;^UTILITY(U,$J,358.3,49207,2)
+20 ;;=^5001752
+21 ;;^UTILITY(U,$J,358.3,49208,0)
+22 ;;=C85.89^^187^2437^29
+23 ;;^UTILITY(U,$J,358.3,49208,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,49208,1,3,0)
+26 ;;=3^NHL NEC,Extranodal & Solid Organ
+27 ;;^UTILITY(U,$J,358.3,49208,1,4,0)
+28 ;;=4^C85.89
+29 ;;^UTILITY(U,$J,358.3,49208,2)
+30 ;;=^5001730
+31 ;;^UTILITY(U,$J,358.3,49209,0)
+32 ;;=C79.51^^187^2437^33
+33 ;;^UTILITY(U,$J,358.3,49209,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,49209,1,3,0)
+36 ;;=3^Secondary Malig Neop Bone
+37 ;;^UTILITY(U,$J,358.3,49209,1,4,0)
+38 ;;=4^C79.51
+39 ;;^UTILITY(U,$J,358.3,49209,2)
+40 ;;=^5001350
+41 ;;^UTILITY(U,$J,358.3,49210,0)
+42 ;;=C79.52^^187^2437^32
+43 ;;^UTILITY(U,$J,358.3,49210,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,49210,1,3,0)
+46 ;;=3^Secondary Malig Neop Bone Marrow
+47 ;;^UTILITY(U,$J,358.3,49210,1,4,0)
+48 ;;=4^C79.52
+49 ;;^UTILITY(U,$J,358.3,49210,2)
+50 ;;=^5001351
+51 ;;^UTILITY(U,$J,358.3,49211,0)
+52 ;;=C92.00^^187^2437^26
+53 ;;^UTILITY(U,$J,358.3,49211,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,49211,1,3,0)
+56 ;;=3^Myelobl Leuk,Acute,No Remiss
+57 ;;^UTILITY(U,$J,358.3,49211,1,4,0)
+58 ;;=4^C92.00
+59 ;;^UTILITY(U,$J,358.3,49211,2)
+60 ;;=^5001789
+61 ;;^UTILITY(U,$J,358.3,49212,0)
+62 ;;=C92.40^^187^2437^31
+63 ;;^UTILITY(U,$J,358.3,49212,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,49212,1,3,0)
+66 ;;=3^Promyelocyt Leuk,Acute,No Remiss
+67 ;;^UTILITY(U,$J,358.3,49212,1,4,0)
+68 ;;=4^C92.40
+69 ;;^UTILITY(U,$J,358.3,49212,2)
+70 ;;=^5001801
+71 ;;^UTILITY(U,$J,358.3,49213,0)
+72 ;;=C92.50^^187^2437^28
+73 ;;^UTILITY(U,$J,358.3,49213,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,49213,1,3,0)
+76 ;;=3^Myelomonocyt Leuk,Acute,No Remiss
+77 ;;^UTILITY(U,$J,358.3,49213,1,4,0)
+78 ;;=4^C92.50
+79 ;;^UTILITY(U,$J,358.3,49213,2)
+80 ;;=^5001804
+81 ;;^UTILITY(U,$J,358.3,49214,0)
+82 ;;=C78.7^^187^2437^37
+83 ;;^UTILITY(U,$J,358.3,49214,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,49214,1,3,0)
+86 ;;=3^Secondary Malig Neop Liver & Intrahep BD
+87 ;;^UTILITY(U,$J,358.3,49214,1,4,0)
+88 ;;=4^C78.7
+89 ;;^UTILITY(U,$J,358.3,49214,2)
+90 ;;=^5001339
+91 ;;^UTILITY(U,$J,358.3,49215,0)
+92 ;;=C91.10^^187^2437^5
+93 ;;^UTILITY(U,$J,358.3,49215,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,49215,1,3,0)
+96 ;;=3^Lymphocyt Leuk B-Cell,Chr,No Remiss
+97 ;;^UTILITY(U,$J,358.3,49215,1,4,0)
+98 ;;=4^C91.10
+99 ;;^UTILITY(U,$J,358.3,49215,2)
+100 ;;=^5001765
+101 ;;^UTILITY(U,$J,358.3,49216,0)
+102 ;;=D46.9^^187^2437^27
+103 ;;^UTILITY(U,$J,358.3,49216,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,49216,1,3,0)
+106 ;;=3^Myelodysplastic Syndrome,Unspec
+107 ;;^UTILITY(U,$J,358.3,49216,1,4,0)
+108 ;;=4^D46.9
+109 ;;^UTILITY(U,$J,358.3,49216,2)
+110 ;;=^334031
+111 ;;^UTILITY(U,$J,358.3,49217,0)
+112 ;;=C79.31^^187^2437^34
+113 ;;^UTILITY(U,$J,358.3,49217,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,49217,1,3,0)
+116 ;;=3^Secondary Malig Neop Brain
+117 ;;^UTILITY(U,$J,358.3,49217,1,4,0)
+118 ;;=4^C79.31
+119 ;;^UTILITY(U,$J,358.3,49217,2)
+120 ;;=^5001347
+121 ;;^UTILITY(U,$J,358.3,49218,0)
+122 ;;=C79.32^^187^2437^35
